XML 8 R1.htm IDEA: XBRL DOCUMENT v3.25.1
Cover - USD ($)
 12 Months Ended
Dec. 31, 2024
Apr. 28, 2025
Jun. 30, 2024
Document Information [Line Items]      
Document Type 10-K/A    
Document Annual Report true    
Document Transition Report false    
Document Financial Statement Error Correction [Flag] false    
Entity Interactive Data Current Yes    
ICFR Auditor Attestation Flag false    
Amendment Flag true    
Amendment Description This Amendment No. 1 (this “Amendment”) amends Bluejay Diagnostics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the “Commission”) on March 31, 2025 (the “Original Form 10-K”). The purpose of this Amendment is to amend Part III, Items 10 through 14 of the Original Form 10-K to include information previously omitted from the Original Form 10-K in reliance on General Instruction G to Form 10-K, which provides that registrants may incorporate by reference certain information from a definitive proxy statement filed with the Commission within 120 days of the fiscal year end, which involves the election of directors. The Company’s definitive proxy statement will not be filed on or before April 30, 2025 (i.e., within 120 days after end of the Company’s 2024 fiscal year) pursuant to Regulation 14A. The reference on the cover of the Original Form 10-K to the incorporation by reference of the registrant’s definitive proxy statement into Part III of the Annual Report is hereby deleted. The Company has also included in this Amendment an amendment pursuant to Part II, Item 9B to disclose recent developments regarding the composition of the Company’s Board of Directors (the “Board”).In addition, as required by Rule 12b-15 under the Securities and Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by our principal executive and financial officer are filed as exhibits to this Amendment under Item 15 of Part IV hereof.For purposes of this Amendment, and in accordance with Rule 12b-15 under the Exchange Act, Items 10 through 14 of the Original Form 10-K have been amended and restated in their entirety. Except as stated herein, this Amendment does not reflect events occurring after the filing of the Original Form 10-K and no attempt has been made in this Amendment to modify or update other disclosures as presented in the Original Form 10-K.    
Document Period End Date Dec. 31, 2024    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Entity Information [Line Items]      
Entity Registrant Name Bluejay Diagnostics, Inc.    
Entity Central Index Key 0001704287    
Entity File Number 001-41031    
Entity Tax Identification Number 47-3552922    
Entity Incorporation, State or Country Code DE    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Shell Company false    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Public Float     $ 1,700,000
Entity Contact Personnel [Line Items]      
Entity Address, Address Line One 360 Massachusetts Avenue    
Entity Address, Address Line Two Suite 203    
Entity Address, City or Town Acton    
Entity Address, State or Province MA    
Entity Address, Postal Zip Code 01720    
Entity Phone Fax Numbers [Line Items]      
City Area Code (844)    
Local Phone Number 327-7078    
Entity Listings [Line Items]      
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol BJDX    
Security Exchange Name NASDAQ    
Entity Common Stock, Shares Outstanding   1,494,167